CAR-T cell therapy for juvenile-onset autoimmune diseases: a promising future?

Abstract Chimeric antigen receptor (CAR) T-cell therapy targeting B cells has shown promising results, including drug-free remission, in adult-onset autoimmune diseases. Extending this therapeutic approach to the pediatric population, particularly for juvenile autoimmune diseases, presents an exciti...

Full description

Saved in:
Bibliographic Details
Main Authors: Maurine Jouret, Sebastien Viel, Benjamin Fournier, Sarah Benezech, Jérome Avouac, Marc Scherlinger, Alexandre Belot, for the C3I consortium
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Arthritis Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13075-025-03564-1
Tags: Add Tag
No Tags, Be the first to tag this record!